Skip to main content
Clinical Trials/NCT03835104
NCT03835104
Terminated
Not Applicable

Urine and CRP Tests at the Point-of-care for the Diagnostic Assessment of Acutely Ill Children: a Diagnostic and Prognostic Study

KU Leuven1 site in 1 country868 target enrollmentFebruary 12, 2019
ConditionsInfection

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infection
Sponsor
KU Leuven
Enrollment
868
Locations
1
Primary Endpoint
Urinary tract infection
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

This study aims to assess the accuracy of a novel urine test for diagnosing urinary tract infections in acutely ill children presenting to ambulatory care. The accuracy of this novel test will be compared to the accuracy of conventional dipstick testing. In addition, the evidence on urine tests will be added to the existing algorithm for diagnosing serious infections in children. Finally, the study aims to describe the relation between the CRP level at study entry and the duration of symptoms and final diagnosis over the following 30 days.

Detailed Description

The design is a cross-sectional cohort study with a nested longitudinal follow-up in acutely children presenting to ambulatory care. The cross-sectional cohort study will compare an innovative urine test with conventional dipstick testing to establish their relative accuracy to diagnose urinary tract infections, and construct an algorithm consisting of clinical features, urine test results and CRP point-of-care testing to identify serious infections. The longitudinal follow-up study will describe illness trajectories of children with an intermediate CRP test result (5-80 mg/L) at first contact. The study will run in general practices and community paediatrics in Flanders. Recruitment to the study is expected to last 18 months, with each patient entering the study only once. Children and their parents/guardians will be approached for possible participation in the study by practice staff. There is only one study visit. Those who agree to participation via written informed consent will have demographics and clinical features recorded. All children will be asked to provide a urine sample on study entry. Subsequently, CRP point-of-care testing will be conducted in all children testing positive on a clinical prediction rule, and in a random sample of children testing negative on that rule. Follow-up information for all children will be collected using general practice notes, hospital records and direct patient/parent contact. Treatment and other management decisions will be left to the treating physicians' discretion.

Registry
clinicaltrials.gov
Start Date
February 12, 2019
End Date
May 22, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
KU Leuven
Responsible Party
Principal Investigator
Principal Investigator

Ann Van den Bruel

Associate Professor

KU Leuven

Eligibility Criteria

Inclusion Criteria

  • Aged 3 months to 18 years
  • Presenting to a general practice or community paediatrics
  • Acute illness of a maximum of 10 days
  • Parent or guardian is willing and able to give informed consent for participation

Exclusion Criteria

  • Clinically unstable warranting immediate care
  • Urinary catheter in situ
  • Immunosuppressant medication taken in the previous 30 days
  • Trauma is the main presenting problem
  • Antibiotics taken in the previous 7 days
  • Children who present to community paediatrics as a result of direct GP referral

Outcomes

Primary Outcomes

Urinary tract infection

Time Frame: 3 days

The number of children with a urinary tract infection based on urine culture

Secondary Outcomes

  • Serious infections(30 days)

Study Sites (1)

Loading locations...

Similar Trials